Colfax Plans To Split To Form Separate Medtech And Fabtech Companies
The yet-to-be-named medtech company will focus on orthopedic implants and bracing and recovery devices.
You may also be interested in...
During the second quarter of 2021, device company M&A values reached $2bn, while in vitro diagnostic firms and research tools players completed M&A activity that totaled $4.4bn.
The resurgence of the pandemic during the fourth quarter of 2020 led to slowdown in elective procedures, negatively impacting sales of the four big ortho players.
Despite COVID-19, the market for extremity replacement implants looks healthy in the medium-term, with strong growth predicted as elective surgeries return.